Ascendis Pharma A/S Announces Second Quarter 2018 Financial Results and Business Update Conference Call on August 29
COPENHAGEN, Denmark, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq:ASND), a biopharmaceutical company that ... Read More
Ascendis Pharma A/S Announces Participation in the 2018 Wedbush PacGrow Healthcare Conference
COPENHAGEN, Denmark, Aug. 02, 2018 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND), a biopharmaceutical company that... Read More